Quality of Life in rural and urban populations in Lebanon using SF-36 Health Survey

Health and Quality of Life Outcomes

Mariette Mercier¹  Nathalie Retel-Rude¹  Sanaa Sabbah²  Nabil Drouby³  Ibtissam Sabbah¹ 

[1] Department of Biostatistics, Faculty of Medicine and Pharmacy, Besançon, France;Center of Methodology and Technology of the Information, Franche Comté University, Besançon, France;Department of Nephrology, University Hospital, Saîda, Lebanon

关键词: SF-36.;    rural;    quality of life;    Lebanon;    Arabic;   

Others  :  1217126
DOI  :  10.1186/1477-7525-1-30

 received in 2003-04-24, accepted in 2003-08-06,  发布年份 2003

【 摘 要 】

Background

Measuring health status in a population is important for the evaluation of interventions and the prediction of health and social care needs. Quality of life (QoL) studies are an essential complement to medical evaluation but most of the tools available in this area are in English. In order to evaluated QoL in rural and urban areas in Lebanon, the short form 36 health survey (SF-36) was adapted into Arabic.

Methods

SF-36 was administered in a cross-sectional study, to collect sociodemographic and environmental variables as well as self reported morbidity. We analysed a representative sample containing 1632 subjects, from whom we randomly picked 524 subjects aged 14 years and over. The translation, cultural adaptation and validation of the SF-36 followed the International Quality of Life Assessment methodology. Multivariate analysis (generalized linear model) was performed to test the effect of habitat (rural on urban areas) on all domains of the SF-36.

Results

The rate of missing data is very low (0.23% of items). Item level validation supported the assumptions underlying Likert scoring. SF-36 scale scores showed wide variability and acceptable internal consistency (Cronbach's alpha >0.70), factor analysis yielded patterns of factor correlation comparable to that found in the U.S.A and France. Patients resident in rural areas had higher vitality scores than those in urban areas. Older people reported more satisfaction with some domains of life than younger people, except for physical functioning. The QoL of women is poorer than men; certain symptoms and morbidity independently influence the domains of SF-36 in this population.

Conclusion

The results support the validity of the SF-36 Arabic version. Habitat has a minor influence on QoL, women had a poor QoL, and health problems had differential impact on QoL.

【 授权许可】

   
2003 Sabbah et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 参考文献 】

• [1]Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M: Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. British Medical Journal 1997, 315:7118-7136.
• [2]Muldoon MF, Barger SD, Flory JD, Manuck SB: What are quality of life measurements measuring? Debate. British Medical Journal 1998, 316:7130-7142.
• [3]Gérin P, Dazord A, Sali A, Boissel JP: L'évaluation de la dépression a la lumière du concept de la qualité de vie subjective. L'Information Psychiatrique 1992, 5(suppl):47-56.
• [4]McKenna SP, Doward LC, Davey KM: The Development and Psychometric Properties of the MSQOL: A Migraine-Specific Quality-of-Life Instrument. Clinical Drug Investigation 1998, 15:413-423.
• [5]Carr AJ, Gibson B, Robinson PJ: Measuring quality of life, Is quality of life determined by expectations or experience? BMJ 2001, 322:1240-1243.
• [6]World Health Organization, Division of Mental Health: Field Trial WHOQOL-100. Geneva 1995.
• [7]Organisation mondiale de la santé, Bureau régional de l'Europe: Les buts de la santé pour tous la politique de santé de l'Europe. Copenhague: Série européenne de la santé pour tous 1993, 4:254.
• [8]Carr AJ, Thompson PW, Kirwan JR: Quality of Life Measures. British Journal of Rheumatology 1996, 35:275-281.
• [9]Testa MA, Simonson DC: Assessment of quality-of-life outcomes. New England Journal of Medicine 1996, 334:835-840.
• [10]Reviriego J, Millan MD, Millan M: Evaluation of the diabetes quality of life questionnaire in a Spanish population. Pharmacoeconomics 1996, 10:614-622.
• [11]Kaplan RM: Profile versus utility based measures of outcome for clinical trials. In Quality of life assessment in clinical trials methods and practice. Edited by Staquet MJ, Hays RD, Fayers PM. Oxford, New York, Tokyo: Oxford University Press; 1998:69-90.
• [12]Anderson RT, Aaronson NK, Bullinger M, McBee WL: A Review of the Progress Towards Developing Health-Related Quality of Life Instruments for International Clinical Studies and Outcomes Research. PharmacoEconomics 1996, 10:336-345.
• [13]Moreno F, Lopez Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F, on behalf of the Spanish Cooperative Renal Patients Quality of Life Study Group: Quality of life in dialysis patients, A Spanish multicentre Study. Nephrol Dial Transplant 1996, 11(suppl 2):125-129.
• [14]Ware JE Jr: The SF-36 Health Survey. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:337-345.
• [15]Ware JE Jr: SF-36 Health Survey Manuel and Interpretation Guide. Second printing. Boston, Massachusetts: The Health Institute, New England Center 1997.
• [16]Ware JE Jr: SF-36 Physical and Mental Health Summary Scales: A User's Manuel, 5th printing. Boston, Health Assessment Lab, New England Center 1994.
• [17]Naughton MJ, Wiklund IK: Dimension-Specific Instruments That May Be Used Across Cultures. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:633-658.
• [18]Badia X, Garcia-Losa M, Dal-Ré R: Ten-language translation and harmonization of the international prostate symptom score: developing a methodology for multinational clinical trials. Eur Urol 1997, 31:129-140.
• [19]Schipper H, Clinch J, Mc Murray A, Lewitt M: Measuring the quality of life of cancer patients. The Functional living index-cancer: Development and validation. J Clin Oncol 1984, 2(5):472-483.
• [20]Mingardi G, for the DIA-QOL Group: From the development to the clinical application of a questionnaire on the quality of life in dialysis. The experience of the Italian Collaborative DIA-QOL (Dialysis-Quality of Life) Group. Nephrol Dial Transplant 1998, 13(suppl 1):70-75.
• [21]Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G, Chang C, Lloyd S, Mo Ma F, Stewart J, Stefoski D: Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996, 47(1):130-138.
• [22]Wasserfallen J-B, Karen G, Schulman KA, Baraniuk JN: Clinical aspects of allergic disease, Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. Journal of allergy and clinical immunology 1997, 100(1):16-22.
• [23]Schraub S, Mercier M, Eschwège F, Lefebvre JL, Vrousos C, Barthod L: A new quality of life questionnaire for head and neck cancers. Epidemiology and public health 1996, 44(4):346-357.
• [24]Tsolaki M, Fountoulakis K, Nakopoulou E, Kazis A, Mohs RC: Alzheimer's disease assessment scale: the validation of the scale in Greece in elderly demented patients and normal subjects. Dement geriatr cogn disord 1997, 8:273-280.
• [25]McKinley Rk, Manku-Scott T, Hastings AM, French DP, Baker R: Reliability and validity of a new measure of patient satisfaction with out of hours primary medical care in the united kingdom: development of a patient questionnaire. British medical journal 1997, 314:7075.
• [26]Eronen MK, Rankinen T, Rauramaa R, Sulkava R, Nissinen A: Clinical investigation, Does Aging Mean A Better Life for Women? Journal of the American Geriatrics Society 1997, 45(5):594-597.
• [27]Bollinger M, Power MJ, Aaronson NK, Cella DF, Anderson RT: Creating and Evaluating Cross-Cultual Instruments. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia, Lippincott-Raven Publishers; 1996:659-668.
• [28]Juniper E: Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997, 99(2):S742-S748.
• [29]Guyatt GH, Jaeschke R, Feeny DH, Patrick DL: Measurements in Clinical Trials: Choosing the Right Approach. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:41-48.
• [30]Anderson RT, McFarlane M, Naughton MJ, Shumaker SA: Conceptual Issues and Considerations in Cross-Cultural Validation of Generic Health-Related Quality of Life Instruments. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:605-612.
• [31]Meers C, Hopman W, Singer MA, Mackenzie TA, Morton AR, McMurray M: A comparison of patient, Nurse, and Physician assessment of Health-Related Quality of Life in End-Stage Renal Disease. E-NEPH Archive. Dialysis and Transplantation 1995, 24(3):120-125.
• [32]Anderson RT, Aaronson NK, Leplège AP, Wilkin D: International Use and Application of Generic Health-Related Quality of Life Instruments. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:613-632.
• [33]Ammar W, Jokhadar A, Awar M: Health Sector Reform in Lebanon. Lebanese Medical Journal 1998, 46(6):328-334.
• [34]World Health Organization: Analysis of National Reports on the Third Evaluation of the Strategy for HFA (Health for All). country Lebanon 1997, 80.
• [35]O.M.S: Rapport sur la santé dans le monde 1999 : Pour un réel changement. Genève 1999.
• [36]Pineault R, Daveluy C: La planification de la santé. Concepts, méthodes, stratégies. 6ème impression. Ottawa: éditions Agence d'ARC inc 1991, 481.
• [37]Coppieters Y, Piette D, Kohn L, De Smet P, health inequalities: self-reported complaints and their predictors in pupils from Belgium. Epidemiology and public health 2002, 50(2):135-146.
• [38]Painter P, Stewart AL, Carey S: Physical Functioning: Definitions, Measurement, and Expectations. Advances in Renal Replacement Therapy 1999, 6:110-123.
• [39]Ifudu O, Paul HR, Homel P, Friedman EA: Predictive Value of Functional Status for Mortality in Patients on Maintenance Hemodialysis. Am J Nephrol 1998, 18:109-116.
• [40]Central Statistics Administration: Conditions de vie des ménages en 1997. Etudes statistiques No 9. Lebanese Republic 1998.
• [41]Researchers Group: Kharitat ahwal al maiicha fi loubnan. Edited by Ministry of Social Affairs, UNDP. Beirut : Dar al Farabi; 1998:173. Published in Arabic
• [42]Ministry of Social Affairs, UNDP: Housing and Population Database. CD-ROM for Windows 1996.
• [43]Mawla M, Awada A, Chreim Z, Fahs R: Mohafazat el Nabatieh, Idara, gographia, tourath. 1ère édition. Liban: Dar Bilal éditeur 1998, 334. Published in Arabic
• [44]Sader (Ed): Decree 116 of 12 June 1959: In Kawanin Loubnan, majmouat al noussouss atachriiyah wa altanzimiya. 6th edition. Beirut, Dar al manchourat alhoukoukiya; 1992:6030-6040.
• [45]World Health Organisation: The International Statistical Classification of Diseases and Related Health Problems, tenth revision, volume 1, ICD-10. Geneva World Health Organisation 1993.
• [46]Gandek B, Ware JE Jr: Methods for validating and norming translations of health status questionnaires : the IQOLA project approach. J Clin Epidemiol 1998, 51:953-959.
• [47]Ware JE Jr, Gandeck BL, Keller SD, and the IQOLA Project Group: Evaluating Instruments Used Cross-Nationally: Methods from the IQOLA Project. In Quality of Life and Pharmacoecoeconomics in Clinical Trials. Second edition. Edited by Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:681-692.
• [48]Leplege A, Ecosse E, Verdier A, Perneger TV: The French SF-36 Health Survey: Translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998, 51:1013-1023.
• [49]Leplège A, Mesbah M, Marquis P: Analyse préliminaire des propriétés psychométriques de la version française d'un questionnaire international de mesure de qualité de vie: le MOS SF-36 (version 1.1). Rev Epidém et Santé Publ 1995, 43(4):371-379.
• [50]Ware JE Jr, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplège A, Prieto L, Sullivan M: The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. J Clin Epidemiol 1998, 51:1159-1165.
• [51]Nunnally JC, Bernstein IH: Psychometric Theory. McGraw-Hill 3rd edition. 1994, 752.
• [52]Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16(3):297-334.
• [53]Hunt SM: Cross-cultural issues in the use of quality of life measures in randomized controlled trials. In Quality of life assessment in clinical trials methods and practice. Edited by Staquet MJ, Hays RD, Fayers PM. Oxford, New York, Tokyo Oxford University Press; 1998:50-67.
• [54]Buchholz W: Assessment of Quality of Life, correspondance. The New England Journal of Medicine 1996, 335:520.
• [55]Thumboo J, Fong K-Y, machin D, Chan S-P, Leong K-H, Feng P-H, Thio S-T, boey M-L: A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore. Quality of Life Research 2001, 10:175-188.
• [56]Malek P, Arzouni K, Adam E, El Ratel A, Faraj P, Aoun D, Rizk HS, Tawil W: El wafi fi jougrafia, 4eme partie, pour la classe de 3ème. In Beyrouth 2nd edition. Edited by Dar el Fikr el Loubnani. 1995. Published in Arabic
• [57]Aïach P: De la mesure des inégalités: enjeux socio-politiques et théoriques. In Les inégalités sociales de santé. Edited by Leclerc A, Fassin H, Grandjean H, Kaminski M, Lang T. Paris, Editions La Découverte/INSERM; 2000:83-91.
• [58]Drulhe M: Santé et société, le façonnement sociétal de la santé. Paris: Sociologie d'aujourd'hui, Presse Universitaires de France 1st edition. 1996, 390.
• [59]Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S: Clinical investigations, Predictors of Quality of Life and Adjustment After Lung Transplantation. Chest 1998., 113(3)
• [60]Evans RW, Manninen DL, Garrison LP Jr, Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG: The quality of life of patients with End-Stage renal disease. The New England Journal of Medicine 1985, 312(9):553-559.
• [61]Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G for the DIA-QOL Group: Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. Nephrol Dial Transplant 1999, 14:1503-1510.
• [62]Fujisawa M, Ichikawa Y, Yoshiya K, Isotani S, Higuchi A, Nagano S, Arakawa S, Hamami G, Matsumoto O, Kamidono S: Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 Health Survey. Urology 2000, 56(2):201-206.